Dr. Merav Cohen, Dr. Tal Laviv and Dr. Eric Shifrut have each been awarded the ERC Starting Grant

updated: 10.02.2022

 Dr. Merav Cohen, PhD, works on immunotherapy targets using single-cell analysis. She is a tenure-track faculty member at the Department of Clinical Microbiology and Immunology, School of Medicine. She received her MSc in the field of Cancer Immunology from the Faculty of Engineering Sciences, Department of Biotechnology Engineering, Ben-Gurion University of the Negev, in a direct MSc track for excellent students, and graduated summa cum laude. She received her PhD in the field of ‘Neuro-Immunology’ from the Department of Neurobiology, the Weizmann Institute of Science. Dr. Cohen performed her postdoctoral training in the field of ‘Immuno-Genomics’, at the Department of Immunology at the Weizmann Institute of Science, and at the Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, in the field of ‘Cancer Immunology’. She won the Feinberg Graduate School Prize for Outstanding Achievements in Postdoctoral Research, and the Ministry of Science and Technology Scholarship for Postdoctoral Fellows in Applied and Engineering Science.

 

More information at: https://www.mcohenlab.com/


 

 Dr. Tal Laviv, PhD, works on cognitive decline and neurodegeneration. He is a tenure-track faculty member in the Department of Physiology and Pharmacology, School of Medicine, and the Sagol School of Neuroscience. His PhD in neurobiology was conducted in the Interdisciplinary Doctoral Program in Neurosciences at Tel Aviv University. His postdoctoral research was conducted at the Max Planck Florida Institute for Neuroscience (Jupiter, Florida). He received a BSc in the Joint Program in Life and Medical Sciences at Tel Aviv University. Dr. Laviv received two international postdoctoral fellowships, from the European Molecular Biology Organization (EMBO) and the Human Frontiers Science Program (HFPS).  

 

More information at: https://www.lavivlab.com/


 

‚Äč Dr. Eric Shifrut, PhD, works on immuno-oncology and cell engineering. He is a tenure-track faculty member and holds a joint position at the Department of Pathology, School of Medicine and the Faculty of Life Sciences at Tel Aviv University and is a principal investigator at the Tel-Aviv Sourasky Medical Center. Dr. Shifrut completed his graduate studies under the mentorship of Prof. Nir Friedman at the Weizmann Institute of Science, mapping the TCR repertoire in health and disease. For his postdoctoral training, he joined Alex Marson at UCSF and Gladstone Institutes to pioneer CRISPR discovery platforms to study primary human T cells. Shifrut’s laboratory is located at the Tel-Aviv Sourasky Medical Center.

 

More information at: https://www.shifrut-lab.org/

 

About the ERC starting grants

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>